Source: FDA · August 11, 2026 · Ongoing · Official government notice
CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity. Nationwide in the USA
CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity. Nationwide in the USA